HOME
ABOUT US
ADVERTISE
SUBSCRIBE
SITE MAP
HELP
CONTACT
WORK FOR US
Friday
10 September 2010
Make BTN my HomePage
INDUSTRY ISSUES STORIES
[ 1323 Results - Showing Results 1 to 30 ]
Research frameworks must change
(Thursday, 9 September 2010)
NATIONAL alliance Research Australia will debut a proposed policy framework for medical research in October, and debate how collaboration may be encouraged in both the research sector and wider industry.
Full Story...
In Silico: Is the IPO window cracking open?
(Tuesday, 7 September 2010)
THE eyes of the biotech sector will be on Broadvector this month, as the company hits the road to spruik its $8.5 million initial public offering.
Full Story...
In Silico: More signs the FDA is toughening up
(Tuesday, 31 August 2010)
IT’S no secret the US Food and Drug Administration has been under sustained pressure over the last few years to toughen up its approvals process. While the FDA has traditionally been regarded as one of the more conservative drug approvals agencies, a number of public scandals in recent years has increased public and legislative pressure on the agency to raise the barriers.
Full Story...
In Silico: The verdict – a plague on both their houses
(Tuesday, 24 August 2010)
WHICHEVER way the chips fall in Canberra in the coming weeks, the outcome will certainly be a minority government. And the other certainty is that it will be a lean few years for life science companies hoping for a little more assistance from the federal government.
Full Story...
Innovators re-elected, Australia waits
(Sunday, 22 August 2010)
AS political leaders court Greens and independents to shore-up new coalitions, Innovation and Industry Minister Kim Carr and shadow minister Sophie Mirabella have been re-elected by voters.
Full Story...
Mirabella talks biotech, dollars
(Thursday, 19 August 2010)
FOLLOWING yesterday’s launch of the Liberal innovation policy,
BTN
asked Shadow Innovation Minister
Sophie Mirabella
to outline how her party’s policies would benefit the biotechnology industry. Here, Mirabella responds.
Full Story...
Libs abandon R&D tax credit to 'bring certainty'
(Thursday, 19 August 2010)
THE Coalition has released its innovation policy, promising to abandon the research and development tax credit and tip $11.4 million into the coffers of the Research Training Scheme.
BTN
spoke to industry and both sides of politics about potential effects on the life sciences.
Full Story...
Virax falls on HIV result
(Tuesday, 17 August 2010)
VIRAX has lost some 60% of its market capitalisation after investors punished it for the poor result from its HIV vaccine trial, which failed to elicit an immune response and missed primary and secondary endpoints.
Full Story...
ASIC eyeballs bottom line
(Thursday, 12 August 2010)
FOLLOWING the transfer of market supervision from the Australian Securities Exchange to the Australian Securities and Investments Commission earlier this month, ASX queries are rolling in, with Giaconda, AnaeCo and Benitec being the latest to respond to questions about their financials.
Full Story...
Biotech Capital liquidating investments
(Thursday, 12 August 2010)
IN a sign of changing times, BioTech Capital has changed its investment strategy and will cash out its investments to shareholders within 18 months.
Full Story...
Setting the innovation agenda
(Tuesday, 10 August 2010)
INNOVATION and Industry Minister Kim Carr has criticised Liberal party leader Tony Abbott for having no policy on innovation, science and research.
Full Story...
In Silico: Is big pharma getting it horribly wrong?
(Tuesday, 10 August 2010)
BIG pharma’s research and development woes have been well picked over, and the shift to the new wisdom of smaller, more nimble biotechs rather than in-house R&D programs is well underway. But the mining sector has undergone a similar transformation in recent decades. Is there anything the life science sector can learn from the minerals sector?
Full Story...
Eastland mourns director *UPDATED*
(Monday, 9 August 2010)
MALARIA treatment developer Eastland Medical Systems has announced the death of shareholder and non-executive director Calvin Ross and a successful $2.3 million placement.
Full Story...
111 days later
(Monday, 9 August 2010)
FOLLOWING a recent Australian Securities Exchange query to a company in administration, a Narhex Life Sciences administrator has officially notified the market of three new directors and their shareholdings.
Full Story...
Bio Briefs: Stirling, BPH, Phylogica and more *UPDATED*
(Thursday, 5 August 2010)
STIRLING Products has responded to an Australian Securities Exchange query regarding its June quarterly, arguing the report disclosed factors relevant to its financial position, including $1.1 million of mezzanine funding, discussions with institutional investors and sales of Sydney CBD properties.
Full Story...
IN FOCUS: The lure of a dual-listing
(Thursday, 5 August 2010)
THE SIX Swiss Exchange is Europe’s leading stock market for the life sciences, holding close to 40% of the sector’s European market capitalisation. Montreux Management chief executive Jerome Nugent-Smith, an organiser of a number of upcoming roadshows, told
BTN
there were clear benefits to listing on the Swiss exchange for life science and clean technology companies.
Full Story...
Solagran takes BioProspect dispute to lawyers
(Thursday, 5 August 2010)
SOLAGRAN has disputed an announcement from partner BioProspect and has referred the matter to its lawyers.
Full Story...
Benitec-CSIRO wait on USPTO decision
(Thursday, 5 August 2010)
REPRESENTATIVES of RNAi developer Benitec and licensor CSIRO have attended a hearing of the US Patent and Trademark Office’s appeals board to re-examine the validity of a number of contested claims of the Graham patent for the control of gene expression – but have left without a decision.
Full Story...
Sunshine needs carry-on cap raising
(Tuesday, 3 August 2010)
SUNSHINE Heart has told ASX Markets Supervision it is planning a capital raising, confirming it may not have funds to conduct ongoing activities if it fails to raise more capital before the fourth quarter.
Full Story...
'Clean 21' policy to harness biotech
(Thursday, 29 July 2010)
INNOVATION and Industry Minister Kim Carr has delivered a pitch for an Australian Labor Party 21st century manufacturing policy which aims to reduce pollution and fight climate change by harnessing biotechnology and nanotechnology to transform process and reduce emissions.
Full Story...
OPINION: Soybean makes a meal of broad patents
(Thursday, 22 July 2010)
A RECENT, landmark European ruling in the Monsanto case will affect the scope of patents being granted to Australian biotech companies – and will retrospectively apply. Wrays Intellectual Property consultant
Carel Smit
and
Dr Rebecca McCrackan
take a look at the “soya bean” decision.
Full Story...
In Silico: Don’t bet on the R&D tax bills anytime soon
(Tuesday, 20 July 2010)
PRIME Minister Julia Gillard’s decision to go to the polls on August 21 effectively puts an end to the chances of seeing the research and development tax credit changes introduced anytime soon. With the civil service and the government in caretaker mode and Parliament prorogued, the bills won’t be back for some time.
Full Story...
In Silico: It's time for a Euro education
(Tuesday, 13 July 2010)
THERE was an interesting piece in the
Financial Times
earlier this month, one that I completely failed to notice at the time. The article, based on new research on drug pricing, put the case that the gap between US and European drug prices isn’t as great as is generally assumed.
Full Story...
Bio People: Starpharma, Avexa
(Tuesday, 13 July 2010)
NANOTECHNOLOGY developer Starpharma has selected long-time CSL employee Malcolm McColl its new vice-president of business development.
Full Story...
Bioscience and medtech join up in NZ
(Friday, 9 July 2010)
BIOSCIENCE industry body NZBIO has formed an alliance with the Medical Technology Association of New Zealand to help bring together the nation’s diverse technologies of biological and medical sciences.
Full Story...
Bio Briefs: SA + the feds, Cortical and more
(Friday, 9 July 2010)
THE South Australia and federal governments have opened a new $7 million funding round for their South Australia Innovation and Investment Fund to create 300 more jobs in the state.
Full Story...
Bio Briefs: SirTex, Medical Australia, Solagran and more
(Thursday, 8 July 2010)
SIRSPHERES inventor and Sirtex founder Dr Bruce Gray has appealed a Federal Court of Australia ruling that he pay SirTex $2.6 million.
Full Story...
Third broker banned for GTG manipulation
(Tuesday, 6 July 2010)
A QUEENSLAND broker has been banned from providing financial services for three years for allegedly engaging in market manipulation in 2006 by trading shares in gene patents and cancer diagnostics company Genetic Technologies.
Full Story...
HealthLinx defends OvPlex
(Tuesday, 6 July 2010)
HEALTHLINX chairman Greg Rice has responded to claims by a leading women’s cancer organisation that there is no proof the company’s OvPlex ovarian cancer test will save lives, saying HealthLinx has completed a scientifically sound and valid trial of OvPlex and it is a better test than CA125.
Full Story...
FDA says CSL deviated from CGMP *UPDATED*
(Tuesday, 29 June 2010)
THE US Food and Drug Administration has issued an “untitled letter” to CSL after it detected a number of deviations from current good manufacturing practice in the production of seasonal flu and H1N1 vaccines at CSL Biotherapies in Victoria – including a possible mercury interaction.
Full Story...
Prev
Next
Company Search
Story Search
Advanced Search
UPCOMING
EVENTS
ABIC 2010 - Bridging Biology and Business
14th International Biotechnology Symposium & Exhibition 2010
BIO India Partnering Conference 2010
OZBIO2010
2010 Livestock Biotech Summit
BioPartnering Europe
View all events
LATEST NEWS
Novogen offers treats to Marshall
Research frameworks must change
Agenix shines like $5M diamonds
Phylogica warns of $106M uncertainty
Bio People: ARTrinsic, iNova
UBI seeks CEO
BioDiem orphaned by FDA
BioDiem fights bird flu with CDC-Merck
Broadvector prepares $24.5M bang
Bio People: Australia, Research Australia, KarmelSonix and more *UPDATED*
Disclaimer
|
© Copyright Aspermont Ltd
|
Privacy Policy
|
Terms and Conditions
